{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:38:57Z","timestamp":1791427137127,"version":"4.3.3"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semcancer.2019.11.013","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T02:39:14Z","timestamp":1577327954000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"special_numbering":"C","title":["Tumor intrinsic and extrinsic immune functions of CD155"],"prefix":"10.1016","volume":"65","author":[{"given":"Jake. S.","family":"O\u2019Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Madore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"6024","key":"10.1016\/j.semcancer.2019.11.013_bib0010","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.semcancer.2019.11.013_bib0015","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2019.11.013_bib0020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"26","key":"10.1016\/j.semcancer.2019.11.013_bib0025","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc.2016.2","article-title":"Acquired resistance to immunotherapy and future challenges","volume":"16","author":"Restifo","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.semcancer.2019.11.013_bib0035","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/sj.onc.1208409","article-title":"Transcriptional activation of the mouse Necl-5\/Tage4\/PVR\/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf\u2013MEK\u2013ERK\u2013AP-1 pathway","volume":"24","author":"Hirota","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41423-018-0168-y","article-title":"Targeting PVR (CD155) and its receptors in anti-tumor therapy","volume":"16","author":"Ku\u010dan Brli\u0107","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.11.013_bib0045","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1172\/JCI98769","article-title":"CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms","volume":"128","author":"Li","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/viro.2001.0943","article-title":"The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin","volume":"285","author":"Lange","year":"2001","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0055","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.bbrc.2004.05.111","article-title":"Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts","volume":"319","author":"Oda","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.semcancer.2019.11.013_bib0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ajpath.2012.11.037","article-title":"Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99","volume":"182","author":"Sullivan","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.11.013_bib0065","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20032206","article-title":"DNAM-1 and PVR regulate monocyte migration through endothelial junctions","volume":"199","author":"Reymond","year":"2004","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2019.11.013_bib0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2457","article-title":"Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation","volume":"9","author":"Takai","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"35","key":"10.1016\/j.semcancer.2019.11.013_bib0075","doi-asserted-by":"crossref","first-page":"36419","DOI":"10.1074\/jbc.M406340200","article-title":"Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5\/Tage4\/Poliovirus Receptor\/CD155 through the Ras-Raf-MEK-ERK signaling","volume":"279","author":"Kakunaga","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2019.11.013_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2017.09.001","article-title":"Poliovirus Receptor: more than a simple viral receptor","volume":"242","author":"Bowers","year":"2017","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(89)90690-9","article-title":"Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily","volume":"56","author":"Mendelsohn","year":"1989","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2019.11.013_bib0090","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1002\/j.1460-2075.1990.tb07520.x","article-title":"The poliovirus receptor protein is produced both as membrane-bound and secreted forms","volume":"9","author":"Koike","year":"1990","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.semcancer.2019.11.013_bib0095","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.168.10.5047","article-title":"SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells","volume":"168","author":"Yusa","year":"2002","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.111.256834","article-title":"Necl-5\/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis","volume":"110","author":"Kinugasa","year":"2012","journal-title":"Circ. Res."},{"issue":"33","key":"10.1016\/j.semcancer.2019.11.013_bib0105","doi-asserted-by":"crossref","first-page":"31251","DOI":"10.1074\/jbc.M304166200","article-title":"Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains","volume":"278","author":"Mueller","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2019.11.013_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-4-73","article-title":"CD155\/PVR plays a key role in cell motility during tumor cell invasion and migration","volume":"4","author":"Sloan","year":"2004","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.semcancer.2019.11.013_bib0115","doi-asserted-by":"crossref","first-page":"18015","DOI":"10.1074\/jbc.M312969200","article-title":"Nectin-like molecule-5\/Tage4 enhances cell migration in an integrin-dependent, Nectin-3-independent manner","volume":"279","author":"Ikeda","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.semcancer.2019.11.013_bib0120","doi-asserted-by":"crossref","first-page":"10930","DOI":"10.1158\/0008-5472.CAN-05-1890","article-title":"CD155\/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics","volume":"65","author":"Sloan","year":"2005","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.23080","article-title":"The CD155\/poliovirus receptor enhances the proliferation of ras-mutated cells","volume":"122","author":"Kono","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2019.11.013_bib0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","volume":"4","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1084\/jem.20150785","article-title":"Identification of CD112R as a novel checkpoint for human T cells","volume":"213","author":"Zhu","year":"2016","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0140","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.semcancer.2019.11.013_bib0145","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1158\/0008-5472.CAN-04-2682","article-title":"Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction","volume":"64","author":"Castriconi","year":"2004","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.semcancer.2019.11.013_bib0150","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1084\/jem.20081611","article-title":"Accelerated tumor growth in mice deficient in DNAM-1 receptor","volume":"205","author":"Iguchi-Manaka","year":"2008","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0155","first-page":"2287","article-title":"Clinical significance of CD155 expression in human pancreatic cancer","volume":"35","author":"Nishiwada","year":"2015","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2019.11.013_bib0160","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/cas.13324","article-title":"CD155, an onco-immunologic molecule in human tumors","volume":"108","author":"Gao","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2019.11.013_bib0165","doi-asserted-by":"crossref","first-page":"116543","DOI":"10.1016\/j.lfs.2019.116543","article-title":"CD155 expression in human breast cancer: clinical significance and relevance to natural killer cell infiltration","volume":"231","author":"Triki","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imr.12518","article-title":"TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy","volume":"276","author":"Dougall","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.str.2018.10.023","article-title":"Structural basis for CD96 immune receptor recognition of nectin-like Protein-5, CD155","volume":"27","author":"Deuss","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.semcancer.2019.11.013_bib0185","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.TIR119.001433","article-title":"A platform for extracellular interactome discovery identifies novel functional binding partners for the immune receptors B7-H3\/CD276 and PVR\/CD155","author":"Husain","year":"2019","journal-title":"Mol. Cell Proteomics"},{"issue":"12","key":"10.1016\/j.semcancer.2019.11.013_bib0190","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20150792","article-title":"DNAM-1 controls NK cell activation via an ITT-like motif","volume":"212","author":"Zhang","year":"2015","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/eji.200940234","article-title":"Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection","volume":"40","author":"Cella","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2019.11.013_bib0200","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.4049\/jimmunol.162.11.6572","article-title":"Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence","volume":"162","author":"Vallejo","year":"1999","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.11.013_bib0205","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.0901226","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells","volume":"183","author":"Carlsten","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/icb.2011.15","article-title":"Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients","volume":"90","author":"Sanchez-Correa","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"45","key":"10.1016\/j.semcancer.2019.11.013_bib0215","doi-asserted-by":"crossref","first-page":"39153","DOI":"10.1074\/jbc.M111.264697","article-title":"Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells","volume":"286","author":"Seth","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.semcancer.2019.11.013_bib0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"issue":"25","key":"10.1016\/j.semcancer.2019.11.013_bib0225","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.1074\/jbc.M114.572420","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) receptor\/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2019.11.013_bib0230","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1038\/ncomms15081","article-title":"Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer","volume":"8","author":"Chung","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0235","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An Immune Atlas of Clear Cell Renal Cell Carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"issue":"7764","key":"10.1016\/j.semcancer.2019.11.013_bib0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"issue":"7764","key":"10.1016\/j.semcancer.2019.11.013_bib0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"issue":"7764","key":"10.1016\/j.semcancer.2019.11.013_bib0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8 T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.semcancer.2019.11.013_bib0255","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1172\/JCI81187","article-title":"TIGIT predominantly regulates the immune response via regulatory T cells","volume":"125","author":"Kurtulus","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0265","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI80445","article-title":"TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients","volume":"125","author":"Chauvin","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.semcancer.2019.11.013_bib0270","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.semcancer.2019.11.013_bib0275","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8 T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semcancer.2019.11.013_bib0280","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.4049\/jimmunol.172.7.3994","article-title":"Cutting edge: CD96 (Tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155)","volume":"172","author":"Fuchs","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0285","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ni.2850","article-title":"The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions","volume":"15","author":"Chan","year":"2014","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0290","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/2326-6066.CIR-18-0637","article-title":"CD96 is an immune checkpoint that regulates CD8 T-cell antitumor function","volume":"7","author":"Mittal","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imcb.12205","article-title":"The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cells","volume":"97","author":"Lepletier","year":"2019","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0300","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-15-0944","article-title":"Suppression of metastases using a new lymphocyte checkpoint target for Cancer immunotherapy","volume":"6","author":"Blake","year":"2016","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.semcancer.2019.11.013_bib0305","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1074\/mcp.TIR119.001433","article-title":"A platform for extracellular interactome discovery identifies novel functional binding partners for the immune receptors B7-H3\/CD276 and PVR\/CD155","volume":"18","author":"Husain","year":"2019","journal-title":"Mol. Cell Proteomics"},{"issue":"12","key":"10.1016\/j.semcancer.2019.11.013_bib0310","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.4049\/jimmunol.1401942","article-title":"CD155 (PVR\/Necl5) mediates a costimulatory signal in CD4+ T cells and regulates allergic inflammation","volume":"194","author":"Yamashita-Kanemaru","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0315","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/eji.201546073","article-title":"CD155\/CD226-interaction impacts on the generation of innate CD8(+) thymocytes by regulating iNKT-cell differentiation","volume":"46","author":"Georgiev","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0320","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/ATVBAHA.111.224162","article-title":"CD155 on human vascular endothelial cells attenuates the acquisition of effector functions in CD8 T cells","volume":"31","author":"Escalante","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.semcancer.2019.11.013_bib0325","doi-asserted-by":"crossref","first-page":"192.29","DOI":"10.4049\/jimmunol.194.Supp.192.29","article-title":"Increased expression of CD155 and CD112 on monocytes in septic patients (INC6P.327)","volume":"194","author":"Yan","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0330","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/ATVBAHA.111.224162","article-title":"CD155 on human vascular endothelial cells attenuates the acquisition of effector functions in CD8 T cells","volume":"31","author":"Escalante","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0335","doi-asserted-by":"crossref","first-page":"e54406","DOI":"10.1371\/journal.pone.0054406","article-title":"Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells","volume":"8","author":"Kamran","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0340","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1182\/blood-2005-07-2696","article-title":"Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction","volume":"107","author":"Pende","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semcancer.2019.11.013_bib0345","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1073\/pnas.97.12.6803","article-title":"Intergeneric poliovirus recombinants for the treatment of malignant glioma","volume":"97","author":"Gromeier","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.semcancer.2019.11.013_bib0350","doi-asserted-by":"crossref","first-page":"882","DOI":"10.18632\/oncotarget.594","article-title":"Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma","volume":"3","author":"Bevelacqua","year":"2012","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0355","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1349-7006.2010.01530.x","article-title":"Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma","volume":"101","author":"Nakai","year":"2010","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0360","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gut.49.2.236","article-title":"Overexpression of the CD155 gene in human colorectal carcinoma","volume":"49","author":"Masson","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2019.11.013_bib0365","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.2147\/OTT.S141476","article-title":"CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma","volume":"10","author":"Huang","year":"2017","journal-title":"Onco. Ther."},{"key":"10.1016\/j.semcancer.2019.11.013_bib0370","doi-asserted-by":"crossref","first-page":"108884","DOI":"10.1016\/j.biopha.2019.108884","article-title":"CD155 expression and its prognostic value in postoperative patients with breast cancer","volume":"115","author":"Yong","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.semcancer.2019.11.013_bib0375","doi-asserted-by":"crossref","first-page":"e0152982","DOI":"10.1371\/journal.pone.0152982","article-title":"Increased soluble CD155 in the serum of cancer patients","volume":"11","author":"Iguchi-Manaka","year":"2016","journal-title":"PLoS One"},{"issue":"9\u201310","key":"10.1016\/j.semcancer.2019.11.013_bib0380","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10495-018-1473-8","article-title":"CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis","volume":"23","author":"Gao","year":"2018","journal-title":"Apoptosis"},{"key":"10.1016\/j.semcancer.2019.11.013_bib0385","article-title":"Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma","author":"Lepletier","year":"2019","journal-title":"Cancer Cell (submitted)"},{"issue":"15","key":"10.1016\/j.semcancer.2019.11.013_bib0390","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","article-title":"ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype","volume":"113","author":"Soriani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2019.11.013_bib0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12885-015-1023-5","article-title":"Nitric oxide donors increase PVR\/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation","volume":"15","author":"Fionda","year":"2015","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.semcancer.2019.11.013_bib0400","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1182\/blood-2010-08-300954","article-title":"DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction","volume":"117","author":"Ardolino","year":"2011","journal-title":"Blood"},{"issue":"Pt 12","key":"10.1016\/j.semcancer.2019.11.013_bib0405","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1099\/vir.0.055541-0","article-title":"The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway","volume":"94","author":"Vassena","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"13","key":"10.1016\/j.semcancer.2019.11.013_bib0410","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1182\/blood-2012-08-449025","article-title":"ATM-dependent spontaneous regression of early Emu-myc-induced murine B-cell leukemia depends on natural killer and T cells","volume":"121","author":"Croxford","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0415","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/JID.2015.404","article-title":"Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase","volume":"136","author":"Inozume","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.11.013_bib0420","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/pcmr.12340","article-title":"PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1\/PD-L1 clinical trials","volume":"28","author":"Madore","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"issue":"127","key":"10.1016\/j.semcancer.2019.11.013_bib0425","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.semcancer.2019.11.013_bib0430","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1158\/1078-0432.CCR-16-0698","article-title":"Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma","volume":"23","author":"Vilain","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0435","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-4-73","article-title":"CD155\/PVR plays a key role in cell motility during tumor cell invasion and migration","volume":"4","author":"Sloan","year":"2004","journal-title":"BMC Cancer"},{"issue":"30","key":"10.1016\/j.semcancer.2019.11.013_bib0440","doi-asserted-by":"crossref","first-page":"28167","DOI":"10.1074\/jbc.M303586200","article-title":"Tage4\/Nectin-like molecule-5 heterophilically trans-interacts with cell adhesion molecule Nectin-3 and enhances cell migration","volume":"278","author":"Ikeda","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.semcancer.2019.11.013_bib0445","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M201378200","article-title":"Expression of the human poliovirus receptor\/ CD155 gene is activated by sonic hedgehog","volume":"277","author":"Solecki","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.semcancer.2019.11.013_bib0450","doi-asserted-by":"crossref","first-page":"e1445949","DOI":"10.1080\/2162402X.2018.1445949","article-title":"Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis","volume":"7","author":"Harjunp\u00e4\u00e4","year":"2018","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0455","first-page":"7312","article-title":"Overexpression of CD155 relates to metastasis and invasion in osteosarcoma","volume":"15","author":"Zhuo","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2019.11.013_bib0460","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2017.06.037","article-title":"CD155 blockade improves survival in experimental sepsis by reversing dendritic cell dysfunction","volume":"490","author":"Meng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.semcancer.2019.11.013_bib0465","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/eji.201243072","article-title":"Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR","volume":"43","author":"Stanietsky","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.11.013_bib0470","doi-asserted-by":"crossref","first-page":"e1424677","DOI":"10.1080\/2162402X.2018.1424677","article-title":"CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity","volume":"7","author":"Aguilera","year":"2018","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.11.013_bib0475","first-page":"208","article-title":"Poliovirus receptor CD155-targeted oncolysis of glioma","volume":"6","author":"Merrill","year":"2004","journal-title":"NeuroOncology"},{"issue":"1","key":"10.1016\/j.semcancer.2019.11.013_bib0480","first-page":"1","article-title":"The practical consideration of poliovirus as an oncolytic virotherapy","volume":"5","author":"Denniston","year":"2016","journal-title":"Am. J. Virol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.11.013_bib0485","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jnen\/nly045","article-title":"Poliovirus receptor (CD155) expression in pediatric brain tumors mediates oncolysis of medulloblastoma and pleomorphic xanthoastrocytoma","volume":"77","author":"Thompson","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"21","key":"10.1016\/j.semcancer.2019.11.013_bib0490","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.4103\/0366-6999.244121","article-title":"Comment to \"Recurrent glioblastoma treated with recombinant poliovirus\"","volume":"131","author":"Wang","year":"2018","journal-title":"Chin. Med. J."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19304031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19304031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:42:17Z","timestamp":1760917337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19304031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":98,"alternative-id":["S1044579X19304031"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.11.013","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor intrinsic and extrinsic immune functions of CD155","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}